Morgan Stanley Apollo Endosurgery, Inc. Transaction History

Morgan Stanley

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$9.83 - $9.96 $729,179 - $738,822	74,179 Added 21.65%	416,826 $4.13 Million
Q4 2022 Feb 14, 2023	BUY	$5.91 - $10.14 $2.01 Million - $3.45 Million	340,695 Added 17453.64%	342,647 $3.42 Million
Q2 2022 Oct 27, 2022	SELL	$3.65 - $6.04 $69,660 - $115,273	-19,085 Reduced 90.72%	1,952 $7,000
Q2 2022 Aug 15, 2022	SELL	$3.65 - $6.04 $69,660 - $115,273	-19,085 Reduced 90.72%	1,952 $7,000
Q1 2022 Oct 27, 2022	BUY	$5.01 - $8.77 $95,615 - $167,375	19,085 Added 977.72%	21,037 $128,000
Q1 2022 May 13, 2022	BUY	$5.01 - $8.77 $74,944 - $131,190	14,959 Added 246.12%	21,037 $128,000
Q4 2021 Feb 14, 2022	BUY	$7.64 - $10.11 $21,262 - $28,136	2,783 Added 84.46%	6,078 $51,000
Q3 2021 Nov 15, 2021	BUY	$7.35 - $9.93 $24,218 - $32,719	3,295 New	3,295 $30,000

527K

Ticker APEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 40,686,500
Description
Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to sutures and secure the approximation of tissue through a flexible en...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.